HomeASMB • NASDAQ
Assembly Biosciences Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 9.42M | 62.82% |
Operating expense | 19.36M | 317.69% |
Net income | -8.82M | 2.85% |
Net profit margin | -93.62 | 40.34% |
Earnings per share | -1.17 | 29.52% |
EBITDA | -9.91M | 7.38% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.03M | -19.43% |
Total assets | 99.02M | -17.41% |
Total liabilities | 71.88M | -17.64% |
Total equity | 27.13M | — |
Shares outstanding | 7.64M | — |
Price to book | 3.40 | — |
Return on assets | -22.78% | — |
Return on capital | -74.63% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.82M | 2.85% |
Cash from operations | -23.44M | -27.64% |
Cash from investing | 6.59M | -61.87% |
Cash from financing | 1.92M | — |
Net change in cash | -14.93M | -1,267.31% |
Free cash flow | -8.50M | -21.40% |
Previous close
$12.11
Day range
$12.19 - $12.65
Year range
$7.76 - $19.93
Market cap
95.47M USD
Avg Volume
25.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Headquarters
Website
Employees
73
